JCJames S. Clifford

James S. Clifford

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


James S. Clifford has a total of 61 co-authors. Here are the top co-authors by number of shared publications:

  • George A. Kenna

    Department of Psychiatry and Human Behavior, Brown University Medical School, Providence, RI, USA

    3 shared publications
  • Lorenzo Leggio

    Center for Alcohol and Addiction Studies, Brown University, Providence, RI, USA; Section on Clinical Psychoneuroendocrinology and Neuropsychopharmacology, Laboratory of Clinical and Translational Studies, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, MD, USA; Intramural Research Program, National Institute on Drug Abuse, National Institutes of Health, Baltimore, MD, USA

    3 shared publications
  • Alexis C. Edwards

    Department of Psychiatry, Virginia Institute for Psychiatric and Behavioral Genetics, Virginia Commonwealth University, Richmond, USA

    2 shared publications
  • Carolina L. Haass-Koffler

    Center for Alcohol and Addiction Studies, Brown University, Providence, RI, USA

    2 shared publications
  • Elizabeth Prom-Wormley

    Department of Epidemiology Virginia Commonwealth University Richmond VA USA

    2 shared publications
  • Jessica R. Shoaff

    Center for Alcohol and Addiction Studies, Brown University, Providence, RI, USA

    2 shared publications

Latest Publications

  • The Association Between Health Literacy and Tobacco Use: Results from a Nationally Representative Survey

    by James S. Clifford, Juan Lu, Courtney T. Blondino, Elizabeth K. Do, Elizabeth C. Prom-Wormley

    Dual use of conventional cigarettes and electronic cigarettes presents an emerging public health issue. Previous research has demonstrated a negative relationship between health literacy and conventional cigarette (CIG) use. However, the relationship between health literacy and e-cigarette (ECIG) use remains unclear. This studies examines the possible association of health literacy and CIG, ECIG, or dual use. A multinomial regression was used to model the association between health literacy and current CIG use, current ECIG use, or dual tobacco use status using state-optional data from the 2016 Behavioral Risk Factor Surveillance System (BRFSS; N = 40,404). One-third of the sample (N = 13,478; 33.3%) had initiated tobacco use. Approximately 36.6% of participants exclusively used cigarettes. A smaller proportion of participants were dual users of ECIG and CIGs (7.0%) and e-cigarette exclusive users (4.5%). After adjusting for covariates, higher levels of oral health literacy was associated with lower odds of current dual use. However, there was no significant association between written HL and either conventional cigarette use or electronic cigarette use or after adjusting for covariates. Oral messaging around the dangers of CIG use may be effective at lowering odds of CIG or dual use, especially for those with higher levels of HL. Further research is needed to examine how to best disseminate information regarding the health risks of ECIGs.


  • Developing community-based health education strategies with family history: Assessing the association between community resident family history and interest in health education

    by Elizabeth C. Prom-Wormley, James S. Clifford, Jessica L. Bourdon, Peter Barr, Courtney Blondino, Kevin M. Ball, Joshua Montgomery, Jonathan K. Davis, Joseph E. Real, Alexis C. Edwards, et al.


  • The Genetic and Environmental Influences Contributing to the Association between Electronic and Conventional Cigarette Initiation

    by Elizabeth C Prom-Wormley, James S Clifford, Megan E Cooke, Jennifer Cecilione, Hermine H Maes, Elizabeth Do, Roxann Roberson-Nay

    Introduction: As the use of electronic cigarette (EC) continues to rise in the United States, especially among adolescents and young adults, it is necessary to better understand the factors associated with EC initiation. Specifically, it is unclear how genetic and environmental contributions influence the initiation of EC. Furthermore, the degree to which genetic and environmental influences are shared between EC initiation and conventional cigarette (CC) initiation is unknown. Methods: A sample of young adult twins ages 15–20 (N = 858 individuals; 421 complete twin pairs) was used to estimate the genetic and environmental influences on the liability of initiation unique to EC and CC as well as the degree to which these factors are shared between the two. Approximately 24% of participants initiated the use of EC, 19% initiated the use of CC, and 11% initiated the dual use. Results: Combined contributions of additive genetic and shared environmental influences were significant for CC (ACC = 0.19 [95% confidence interval {CI} = 0–0.79], p = 0.57; CCC = 0.42 [95% CI = 0–0.70], p = 0.13) and EC (AEC = 0.25 [95% CI = 0–0.83, p = 0.44; CEC = 0.42 [95% CI = 0–0.73], p = 0.12), whereas unique environmental influences were significant (ECC = 0.39 [95% CI = 0.18–0.57], p < 0.001; EEC = 0.32 [95% CI = 0.14–0.56], p < 0.001). Results also demonstrated a significant overlap of the unique environmental (rE = 0.87, p < 0.001) and familial influences contributing to correlation between the two phenotypes in the bivariate analysis. Conclusions: These preliminary results suggest that both genes and environmental influences are potential drivers of EC initiation among adolescents and young adults. Implications: This article is the first to use a sample of twin to estimate the contributions of genetic and environmental influences toward EC initiation and estimate the potential for overlapping influences with CC initiation. This study has implications for future debate about the etiology of EC and CC use with respect to potential overlapping genetic and environmental influences.


  • Ondansetron and sertraline may interact with 5-HTTLPR and DRD4 polymorphisms to reduce drinking in non-treatment seeking alcohol-dependent women: Exploratory findings

    by George A. Kenna, William H. Zywiak, Robert M. Swift, John E. McGeary, James S. Clifford, Jessica R. Shoaff, Samuel Fricchione, Michael Brickley, Kayla Beaucage, Carolina L. Haass-Koffler, et al.


  • Ondansetron Reduces Naturalistic Drinking in Nontreatment-Seeking Alcohol-Dependent Individuals with the LL 5′-HTTLPR Genotype: A Laboratory Study

    by George A. Kenna, William H. Zywiak, Robert M. Swift, John E. McGeary, James S. Clifford, Jessica R. Shoaff, Cynthia Vuittonet, Samuel Fricchione, Michael Brickley, Kayla Beaucage, et al.

    Background One hypothesis suggests that the differential response to ondansetron‐ and serotonin‐specific re‐uptake inhibitors (SSRIs) may be due to a functional polymorphism of the 5′‐HTTLPR promoter region in SLC6A4, the gene that codes for the serotonin transporter (5‐HTT). The LL 5′‐HTTLPR genotype is postulated to be specifically sensitive to the effects of ondansetron with SS/SL 5′‐HTTLPR genotypes sensitive to SSRIs. This study tests this hypothesis by matching nontreatment‐seeking alcohol‐dependent (AD) individuals with LL genotype to ondansetron and SS/SL genotypes to the SSRI sertraline, and mismatching them assessing naturalistic and bar–laboratory alcohol drinking. Methods Seventy‐seven AD individuals were randomized to 1 of 2 counterbalanced arms to receive sertraline 200 mg/d or ondansetron 0.5 mg/d for 3 weeks followed by an alcohol self‐administration experiment (ASAE) and then received placebo for 3 weeks followed by a second ASAE. Individuals then received the alternate drug for 3 weeks followed by a third ASAE. Drinks per drinking day (DDD with drinks in standard drinking units) for 7 days prior to each ASAE and milliliters consumed during each ASAE were the primary outcomes. Results Fifty‐five participants completed the study. The genotype × order interaction was significant, F(1, 47) = 8.42, p = 0.006, for DDD. Three analyses of covariance were conducted for DDD during the week before each ASAE. Ondansetron compared to sertraline resulted in a significant reduction in DDD during the week before the first, F(1, 47) = 7.64, p = 0.008, but not the third ASAE. There was no difference in milliliters consumed during each ASAE. Conclusions This study modestly supports the hypothesis that ondansetron may reduce DDD in AD individuals with the LL genotype as measured naturalistically. By contrast, there was no support that ondansetron reduces drinking during the ASAEs or that sertraline reduces alcohol use in individuals who have SS/SL genotypes. We provide limited support that ondansetron may reduce drinking in nontreatment‐seeking individuals with the LL genotype.


  • Open Access

    Spit for Science: launching a longitudinal study of genetic and environmental influences on substance use and emotional health at a large US university

    by Danielle M. Dick, Aashir Nasim, Alexis C. Edwards, Jessica E. Salvatore, Seung B. Cho, Amy Adkins, Jacquelyn Meyers, Jia Yan, Megan Cooke, James Clifford, et al.

    Finding genes involved in complex behavioral outcomes, and understanding the pathways by which they confer risk, is a challenging task, necessitating large samples that are phenotypically well characterized across time. We describe an effort to create a university-wide research project aimed at understanding how genes and environments impact alcohol use and related substance use and mental health outcomes across time in college students. Nearly 70% of the incoming freshman class (N = 2715) completed on-line surveys, with 80% of the students from the fall completing spring follow-ups. 98% of eligible participants also gave DNA. The participants closely approximated the university population in terms of gender and racial/ethnic composition. Here we provide initial results on alcohol use outcomes from the first wave of the sample, as well as associated predictor variables. We discuss the potential for this kind of research to advance our understanding of genetic and environment influences on substance use and mental health outcomes.


  • Open Access

    Association of the 5-HTT gene-linked promoter region (5-HTTLPR) polymorphism with psychiatric disorders: review of psychopathology and pharmacotherapy

    by George A Kenna, Nick Roder-Hanna, Lorenzo Leggio, William H Zywiak, James Clifford, Steven Edwards, John A Kenna, Jessica Shoaff, Robert M Swift

    Peer reviewed article authored by (Kenna GA, Roder-Hanna N, Leggio L, Zywiak WH, Clifford J, Edwards S, Kenna JA, Shoaff J, Swift RM). Read article or submit your manuscript for publishing.